Cytek Biosciences's market cap is currently ―. The company's EPS TTM is $-0.087; its P/E ratio is -65.60; Cytek Biosciences is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 58.23M	$ 48.00M	$ 40.45M	$ 31.17M	$ 48.34M
Gross Profit	$ 33.05M	$ 27.18M	$ 28.16M	$ 21.04M	$ 29.37M
EBIT	$ 4.50M	$ -3.59M	$ -6.19M	$ -10.51M	$ 2.17M
EBITDA	$ 5.53M	$ -2.59M	$ -5.87M	$ -10.29M	$ 3.96M
Net Income Common Stockholders	$ 5.50M	$ -6.46M	$ -4.39M	$ -13.46M	$ 7.02M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 262.41M	$ 287.99M	$ 298.84M	$ 301.91M	$ 344.05M
Total Assets	$ 494.46M	$ 519.43M	$ 525.05M	$ 524.58M	$ 519.48M
Total Debt	$ 11.13M	$ 11.88M	$ 12.71M	$ 13.67M	$ 14.58M
Net Debt	$ -251.28M	$ -276.12M	$ -286.12M	$ -288.24M	$ -329.46M
Total Liabilities	$ 101.39M	$ 103.91M	$ 84.41M	$ 101.11M	$ 93.93M
Stockholders Equity	$ 393.06M	$ 415.52M	$ 440.64M	$ 423.46M	$ 425.55M
Cash Flow	-
Free Cash Flow	$ 7.95M	$ -5.63M	$ -4.22M	$ 2.35M	$ -417.00K
Operating Cash Flow	$ 9.51M	$ -4.24M	$ -2.85M	$ 2.86M	$ 6.19M
Investing Cash Flow	$ 29.07M	$ 43.12M	$ 2.79M	$ -168.87M	$ -51.06M
Financing Cash Flow	$ -33.75M	$ -8.27M	$ 216.00K	-	$ 3.85M

Currency in USD

Cytek Biosciences Earnings and Revenue History

Income Statement >

Cytek Biosciences Debt to Assets

Balance Sheet >

Cytek Biosciences Cash Flow

Cash Flow >

Cytek Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing